Lapatinib is a small molecule 4-anilinoquinazoptor tyrosine kinase inhibitor, Inhibit of epidermal growth factor receptor (ErbB1) and human epidermal factor receptor 2 (ErbB2), treatment of advanced or metastatic breast cancer.
1) Production Capacity: 1000 kgs / month
2) GMP approved workshop to ensure quality
3) Quality Standard: BP Grade, USP Grade, EP Grade, CHP Grade
4) Provide flexible quantity from 1 gram to 25 kg or more
5) Third party lab test such as SGS, BV, Internek
6) Flexible shipment: By courier FEDEX, DHL, UPS, TNT, EMS, by air or sea